Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides

A series of sixteen ring-substituted -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against , three methicillin-resistant strains, H37Ra, , and . Several of the tested compounds showed antistaphylococcal, antitubercular, an...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences Vol. 19; no. 8; p. 2318
Main Authors: Pospisilova, Sarka, Kos, Jiri, Michnova, Hana, Kapustikova, Iva, Strharsky, Tomas, Oravec, Michal, Moricz, Agnes M, Bakonyi, Jozsef, Kauerova, Tereza, Kollar, Peter, Cizek, Alois, Jampilek, Josef
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 07-08-2018
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract A series of sixteen ring-substituted -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against , three methicillin-resistant strains, H37Ra, , and . Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2 )- -[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2 )-3-phenyl- -[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against . These compounds showed an activity against biofilm formation of ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2 )- -(3,5-Dichlorophenyl)- and (2 )- -(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against , while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2 )- -(3-Fluorophenyl)- and (2 )- -(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against . . The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach ( L.) chloroplasts. (2 )- -(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against var. Samsun. The structure⁻activity relationships are discussed.
AbstractList A series of sixteen ring-substituted -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against , three methicillin-resistant strains, H37Ra, , and . Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2 )- -[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2 )-3-phenyl- -[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against . These compounds showed an activity against biofilm formation of ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2 )- -(3,5-Dichlorophenyl)- and (2 )- -(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against , while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2 )- -(3-Fluorophenyl)- and (2 )- -(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against . . The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach ( L.) chloroplasts. (2 )- -(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against var. Samsun. The structure⁻activity relationships are discussed.
A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure-activity relationships are discussed.
A series of sixteen ring-substituted N -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus , three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum , and Bipolaris sorokiniana . Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2 E )- N -[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2 E )-3-phenyl- N -[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis . These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2 E )- N -(3,5-Dichlorophenyl)- and (2 E )- N -(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis , while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2 E )- N -(3-Fluorophenyl)- and (2 E )- N -(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B . sorokiniana . The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach ( Spinacia oleracea L.) chloroplasts. (2 E )- N -(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC 50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed.
: A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed.
: A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M.tuberculosis. These compounds showed an activity against biofilm formation of S.aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure⁻activity relationships are discussed.
Author Kapustikova, Iva
Moricz, Agnes M
Strharsky, Tomas
Pospisilova, Sarka
Michnova, Hana
Bakonyi, Jozsef
Kollar, Peter
Jampilek, Josef
Oravec, Michal
Cizek, Alois
Kos, Jiri
Kauerova, Tereza
AuthorAffiliation 4 Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary; moricz.agnes@agrar.mta.hu (A.M.M.); bakonyi.jozsef@agrar.mta.hu (J.B.)
3 Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic; oravec.m@czechglobe.cz
1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia; sharka.pospisilova@gmail.com (S.P.); michnova.hana@gmail.com (H.M.); kapustikova@fpharm.uniba.sk (I.K.); strharsky2@uniba.sk (T.S.); josef.jampilek@gmail.com (J.J.)
2 Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; cizeka@vfu.cz
5 Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; tereza.kauerova@gmail.com (T.K.);
AuthorAffiliation_xml – name: 2 Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; cizeka@vfu.cz
– name: 3 Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic; oravec.m@czechglobe.cz
– name: 4 Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary; moricz.agnes@agrar.mta.hu (A.M.M.); bakonyi.jozsef@agrar.mta.hu (J.B.)
– name: 5 Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; tereza.kauerova@gmail.com (T.K.); kollarp@vfu.cz (P.K.)
– name: 1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia; sharka.pospisilova@gmail.com (S.P.); michnova.hana@gmail.com (H.M.); kapustikova@fpharm.uniba.sk (I.K.); strharsky2@uniba.sk (T.S.); josef.jampilek@gmail.com (J.J.)
Author_xml – sequence: 1
  givenname: Sarka
  surname: Pospisilova
  fullname: Pospisilova, Sarka
  email: sharka.pospisilova@gmail.com, sharka.pospisilova@gmail.com
  organization: Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. sharka.pospisilova@gmail.com
– sequence: 2
  givenname: Jiri
  surname: Kos
  fullname: Kos, Jiri
  email: jirikos85@gmail.com
  organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. jirikos85@gmail.com
– sequence: 3
  givenname: Hana
  surname: Michnova
  fullname: Michnova, Hana
  email: michnova.hana@gmail.com, michnova.hana@gmail.com
  organization: Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. michnova.hana@gmail.com
– sequence: 4
  givenname: Iva
  surname: Kapustikova
  fullname: Kapustikova, Iva
  email: kapustikova@fpharm.uniba.sk
  organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. kapustikova@fpharm.uniba.sk
– sequence: 5
  givenname: Tomas
  surname: Strharsky
  fullname: Strharsky, Tomas
  email: strharsky2@uniba.sk
  organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. strharsky2@uniba.sk
– sequence: 6
  givenname: Michal
  surname: Oravec
  fullname: Oravec, Michal
  email: oravec.m@czechglobe.cz
  organization: Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic. oravec.m@czechglobe.cz
– sequence: 7
  givenname: Agnes M
  surname: Moricz
  fullname: Moricz, Agnes M
  email: moricz.agnes@agrar.mta.hu
  organization: Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary. moricz.agnes@agrar.mta.hu
– sequence: 8
  givenname: Jozsef
  surname: Bakonyi
  fullname: Bakonyi, Jozsef
  email: bakonyi.jozsef@agrar.mta.hu
  organization: Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary. bakonyi.jozsef@agrar.mta.hu
– sequence: 9
  givenname: Tereza
  surname: Kauerova
  fullname: Kauerova, Tereza
  email: tereza.kauerova@gmail.com
  organization: Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. tereza.kauerova@gmail.com
– sequence: 10
  givenname: Peter
  surname: Kollar
  fullname: Kollar, Peter
  email: kollarp@vfu.cz
  organization: Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. kollarp@vfu.cz
– sequence: 11
  givenname: Alois
  surname: Cizek
  fullname: Cizek, Alois
  email: cizeka@vfu.cz
  organization: Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. cizeka@vfu.cz
– sequence: 12
  givenname: Josef
  orcidid: 0000-0003-2003-9052
  surname: Jampilek
  fullname: Jampilek, Josef
  email: josef.jampilek@gmail.com
  organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. josef.jampilek@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30087309$$D View this record in MEDLINE/PubMed
BookMark eNpdkUtv1DAURi1URB-wY40isWFBwK849gaprWipqMqisLZs53rqUWIPdjJS_z0uU6opKz_u0bnX_o7RQUwREHpL8CfGFP4c1lMhCkvKiHyBjgintMVY9Ad7-0N0XMoaY8pop16hQ4ax7BlWR-j77X2c76CE0pg4NLcbcHNepib55iykMa2CM2Nz6uawDXOA8lC4SVsYm5vW5PvRhRjNZKYwQHmNXnozFnjzuJ6gXxdff55_a69_XF6dn163jvdybh3hXkopBi-s5M5whW1vGHXOK8nBKeeFdJj0lLF6Zp0drMKMcqcs7z1lJ-hq5x2SWetNDlOdRCcT9N-LlFfa5Dm4ETQF6LnjFgTvOBhlPeEYD1bITnglhur6snNtFjvB4CDO2YzPpM8rMdzpVdpqQSjhXVcFHx4FOf1eoMx6CsXBOJoIaSma4tpKyJ7wir7_D12nJcf6VZoSLCWVQqlKfdxRLqdSMvinYQjWD4nr_cQr_m7_AU_wv4jZH7N2qQM
CitedBy_id crossref_primary_10_1002_chem_202301244
crossref_primary_10_3390_ijms20071524
crossref_primary_10_3390_ijms21186583
crossref_primary_10_3390_ijms23063159
crossref_primary_10_1080_10406638_2023_2212106
crossref_primary_10_3390_ijms232315090
crossref_primary_10_1080_17460441_2022_2097659
crossref_primary_10_3390_molecules25184121
crossref_primary_10_3390_ijms24043611
crossref_primary_10_52711_0974_360X_2022_00647
crossref_primary_10_3390_molecules24244531
crossref_primary_10_3390_antibiotics9020064
crossref_primary_10_3390_molecules27227799
crossref_primary_10_3390_ijms20040830
crossref_primary_10_1016_j_drudis_2022_05_006
crossref_primary_10_1016_j_ejmech_2021_113187
crossref_primary_10_2174_1389203720666190913114041
crossref_primary_10_1016_j_bioorg_2020_104060
crossref_primary_10_3390_ijms20215385
crossref_primary_10_1016_j_molstruc_2020_127813
crossref_primary_10_3390_pharmaceutics14122681
crossref_primary_10_1134_S1070428021040102
crossref_primary_10_3390_ma15072388
crossref_primary_10_1016_j_ejmech_2021_113735
crossref_primary_10_1016_j_heliyon_2024_e29051
crossref_primary_10_3390_app11104691
Cites_doi 10.1016/S0732-8893(02)00473-X
10.1099/jmm.0.022426-0
10.1016/S0176-1617(98)80142-9
10.2174/138955712801264792
10.3390/molecules17010613
10.1128/AEM.68.4.1561-1568.2002
10.1016/j.bmcl.2016.07.021
10.1111/jam.12417
10.1186/1471-2180-8-149
10.1371/journal.pone.0176189
10.1016/j.bmc.2012.10.007
10.3390/molecules22081247
10.3390/molecules23051187
10.1002/ps.782
10.3390/molecules15118122
10.3390/molecules22101709
10.1016/j.jksus.2018.02.005
10.5301/ijao.5000027
10.1614/WS-09-102.1
10.1021/acsmedchemlett.7b00196
10.1021/jm101510d
10.1016/j.bmcl.2016.10.091
10.1111/j.1472-765X.2006.02001.x
10.1016/j.bmc.2015.06.047
10.3390/molecules20069767
10.1016/S0076-6879(80)69041-7
10.1016/S0377-8401(98)00278-8
10.3109/13880209.2010.519390
10.1016/j.drudis.2014.08.010
10.1016/j.bmcl.2017.03.050
10.1371/journal.pone.0149317
10.1093/mp/ssp106
10.3390/molecules18089397
10.3390/molecules19079655
10.1371/journal.pone.0002375
10.1111/j.1472-765X.2011.03122.x
10.1007/s00044-012-0093-z
10.1002/jhet.2670
10.3390/molecules191220197
10.1016/j.bmc.2015.03.018
10.1021/np50019a001
10.1155/2015/349534
10.1128/AAC.40.5.1274
10.1002/jobm.201000221
10.1016/j.drudis.2006.07.002
10.3390/microorganisms1010188
10.1104/pp.36.6.788
10.1038/nrd4001
10.1016/j.ijfoodmicro.2014.11.028
10.2174/1381612820666140905114627
10.1016/j.ijfoodmicro.2015.02.009
10.1080/14786419.2017.1317776
10.1128/AEM.00875-09
10.1016/j.ejmech.2010.01.024
10.1007/978-1-4939-1441-8_26
10.1016/j.ijfoodmicro.2006.04.046
10.3390/molecules191219292
10.1517/17460441.2016.1110142
10.1021/jf980154m
10.3390/molecules21081068
10.2174/1871520615666150130111120
10.1016/0005-2728(77)90157-8
10.3390/ijms17081219
10.1016/j.ejps.2011.04.012
10.1021/la303286v
10.2174/1573406410666140815125004
10.1016/j.bmcl.2018.05.011
10.1080/14756360902779326
10.1016/j.bmc.2013.08.030
10.33073/pjm-2011-005
10.1016/j.ejps.2015.06.009
10.1111/1462-2920.12213
10.3109/1040841X.2013.763219
ContentType Journal Article
Copyright 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2018 by the authors. 2018
Copyright_xml – notice: 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2018 by the authors. 2018
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/ijms19082318
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Research Library
Research Library (Corporate)
Access via ProQuest (Open Access)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed


CrossRef
MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID oai_doaj_org_article_2ee74c4be6454ea9bf1400db6856f96d
10_3390_ijms19082318
30087309
Genre Journal Article
GroupedDBID ---
29J
2WC
3V.
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
ABDBF
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESTFP
ESX
F5P
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IPNFZ
ITC
KB.
KQ8
LK8
M1P
M2O
M48
M7P
MODMG
M~E
NPM
O5R
O5S
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
7XB
8FK
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c478t-c14f8886df6b84ca490b7a32ccf984ec9cf68c01723384e35bdb90324c9b47f23
IEDL.DBID RPM
ISSN 1422-0067
1661-6596
IngestDate Tue Oct 22 15:15:37 EDT 2024
Tue Sep 17 21:10:40 EDT 2024
Fri Oct 25 08:18:34 EDT 2024
Thu Oct 10 16:48:57 EDT 2024
Thu Nov 21 20:59:43 EST 2024
Wed Oct 16 00:58:58 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords cinnamamides
toxicity
time-kill assay
antistaphylococcal activity
biofilm
structure–activity relationship
antitubercular activity
PET inhibition
MTT assay
antifungal activity
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c478t-c14f8886df6b84ca490b7a32ccf984ec9cf68c01723384e35bdb90324c9b47f23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2003-9052
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121455/
PMID 30087309
PQID 2108828699
PQPubID 2032341
ParticipantIDs doaj_primary_oai_doaj_org_article_2ee74c4be6454ea9bf1400db6856f96d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6121455
proquest_miscellaneous_2085668714
proquest_journals_2108828699
crossref_primary_10_3390_ijms19082318
pubmed_primary_30087309
PublicationCentury 2000
PublicationDate 2018-08-07
PublicationDateYYYYMMDD 2018-08-07
PublicationDate_xml – month: 08
  year: 2018
  text: 2018-08-07
  day: 07
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2018
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref13
ref57
ref12
ref56
Kralova (ref95) 1992; 46
ref15
ref14
ref58
ref53
ref52
ref10
ref54
ref17
ref16
ref19
Abate (ref92) 1998; 2
Szabo (ref88) 2008; 52
Kralova (ref84) 1992; 11
Tortora (ref77) 2010
De (ref69) 2012
ref51
ref50
ref90
ref46
ref45
ref89
ref48
ref47
ref42
(ref91) 2012
ref44
ref43
ref49
ref8
ref7
ref9
ref3
ref6
ref82
ref81
ref40
ref83
Pliska (ref36) 1996; Volume 4
Kralova (ref87) 1995; 50
De Lucca (ref93) 1996; 40
ref80
Berrin (ref4) 2011; 49
ref35
ref79
ref34
ref78
ref37
ref31
ref75
ref30
ref33
ref32
ref76
ref2
ref1
ref39
ref38
Kralova (ref85) 1994; 49
Masarovicova (ref94) 2005
(ref18) 2017
Trebst (ref22) 1979
Izawa (ref24) 1980; Volume 69
Saari (ref74) 1998
ref71
ref70
Bueno (ref59) 2012
Hadjipavlou-Litina (ref11) 2015; 1208
ref72
Bowyer (ref23) 1991; Volume 10
ref68
ref67
ref26
ref25
Sharma (ref5) 2011; 3
ref20
ref64
Schwalbe (ref41) 2007
ref63
ref66
ref21
ref65
Kralova (ref86) 1994; 49
ref28
ref27
ref29
Budzynska (ref55) 2011; 60
ref60
ref62
Krishnendu (ref73) 2011; 5
ref61
References_xml – ident: ref42
  doi: 10.1016/S0732-8893(02)00473-X
– ident: ref47
  doi: 10.1099/jmm.0.022426-0
– ident: ref1
  doi: 10.1016/S0176-1617(98)80142-9
– ident: ref6
  doi: 10.2174/138955712801264792
– ident: ref19
  doi: 10.3390/molecules17010613
– ident: ref44
  doi: 10.1128/AEM.68.4.1561-1568.2002
– ident: ref81
  doi: 10.1016/j.bmcl.2016.07.021
– ident: ref7
  doi: 10.1111/jam.12417
– ident: ref49
  doi: 10.1186/1471-2180-8-149
– ident: ref72
  doi: 10.1371/journal.pone.0176189
– ident: ref82
  doi: 10.1016/j.bmc.2012.10.007
– volume: 46
  start-page: 348
  year: 1992
  ident: ref95
  article-title: Photosynthesis inhibition produced by 2-alkylthio-6-R-benzothiazoles
  publication-title: Chem. Pap.
  contributor:
    fullname: Kralova
– ident: ref14
  doi: 10.3390/molecules22081247
– volume: 49
  start-page: 857
  year: 1994
  ident: ref86
  article-title: Correlation between biological activity and the structure of N,N’-bis(alkyldimethyl)-1,6-hexanediammonium dibromides. Antibacterial activity and inhibition of photochemical activity of chloroplasts
  publication-title: Pharmazie
  contributor:
    fullname: Kralova
– volume: Volume 4
  year: 1996
  ident: ref36
  article-title: Methods and Principles in Medicinal Chemistry
  contributor:
    fullname: Pliska
– ident: ref16
  doi: 10.3390/molecules23051187
– ident: ref31
  doi: 10.1002/ps.782
– ident: ref26
  doi: 10.3390/molecules15118122
– ident: ref17
– ident: ref30
  doi: 10.3390/molecules22101709
– ident: ref70
  doi: 10.1016/j.jksus.2018.02.005
– ident: ref56
  doi: 10.5301/ijao.5000027
– ident: ref33
  doi: 10.1614/WS-09-102.1
– ident: ref66
  doi: 10.1021/acsmedchemlett.7b00196
– ident: ref68
  doi: 10.1021/jm101510d
– ident: ref13
  doi: 10.1016/j.bmcl.2016.10.091
– volume: 2
  start-page: 1011
  year: 1998
  ident: ref92
  article-title: Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis
  publication-title: Int. J. Tuberc. Lung Dis.
  contributor:
    fullname: Abate
– ident: ref53
  doi: 10.1111/j.1472-765X.2006.02001.x
– ident: ref60
  doi: 10.1016/j.bmc.2015.06.047
– ident: ref61
  doi: 10.3390/molecules20069767
– volume: Volume 69
  start-page: 413
  year: 1980
  ident: ref24
  article-title: Acceptors and donors for chloroplast electron transport
  doi: 10.1016/S0076-6879(80)69041-7
  contributor:
    fullname: Izawa
– ident: ref76
  doi: 10.1016/S0377-8401(98)00278-8
– volume: 49
  start-page: 396
  year: 2011
  ident: ref4
  article-title: Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids
  publication-title: Pharm. Biol.
  doi: 10.3109/13880209.2010.519390
  contributor:
    fullname: Berrin
– ident: ref34
  doi: 10.1016/j.drudis.2014.08.010
– ident: ref29
  doi: 10.1016/j.bmcl.2017.03.050
– ident: ref90
  doi: 10.1371/journal.pone.0149317
– ident: ref2
  doi: 10.1093/mp/ssp106
– ident: ref83
  doi: 10.3390/molecules18089397
– volume: Volume 10
  start-page: 27
  year: 1991
  ident: ref23
  contributor:
    fullname: Bowyer
– volume: 11
  start-page: 261
  year: 1992
  ident: ref84
  article-title: Inhibitory effect of piperidinoethylesters of alkoxyphenylcarbamic acids on photosynthesis
  publication-title: Gen. Physiol. Biophys.
  contributor:
    fullname: Kralova
– ident: ref10
  doi: 10.3390/molecules19079655
– start-page: 617
  year: 2005
  ident: ref94
  article-title: Approaches to Measuring Plant Photosynthesis Activity
  contributor:
    fullname: Masarovicova
– ident: ref58
  doi: 10.1371/journal.pone.0002375
– ident: ref51
  doi: 10.1111/j.1472-765X.2011.03122.x
– ident: ref89
  doi: 10.1007/s00044-012-0093-z
– start-page: 37
  year: 1998
  ident: ref74
  article-title: Leaf blight disease and associated soil borne fungal pathogens of wheat in South and Southeast Asia
  contributor:
    fullname: Saari
– ident: ref65
  doi: 10.1002/jhet.2670
– ident: ref9
  doi: 10.3390/molecules191220197
– ident: ref20
  doi: 10.1016/j.bmc.2015.03.018
– ident: ref80
  doi: 10.1021/np50019a001
– ident: ref37
  doi: 10.1155/2015/349534
– volume: 40
  start-page: 1274
  year: 1996
  ident: ref93
  article-title: N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.40.5.1274
  contributor:
    fullname: De Lucca
– ident: ref57
  doi: 10.1002/jobm.201000221
– volume: 49
  start-page: 460
  year: 1994
  ident: ref85
  article-title: Correlation between biological activity and the structure of 6-amino-2-R-thiobenzothiazoles. Anti-yeast activity and inhibition of photochemical activity of chloroplasts
  publication-title: Pharmazie
  contributor:
    fullname: Kralova
– ident: ref32
  doi: 10.1016/j.drudis.2006.07.002
– ident: ref75
  doi: 10.3390/microorganisms1010188
– ident: ref78
– ident: ref25
  doi: 10.1104/pp.36.6.788
– ident: ref63
  doi: 10.1038/nrd4001
– ident: ref48
  doi: 10.1016/j.ijfoodmicro.2014.11.028
– ident: ref52
  doi: 10.2174/1381612820666140905114627
– start-page: 337
  year: 2012
  ident: ref69
  article-title: Cinnamic derivatives in tuberculosis
  contributor:
    fullname: De
– start-page: 147
  year: 2012
  ident: ref59
  article-title: Antitubercular in vitro drug discovery: Tools for begin the search
  contributor:
    fullname: Bueno
– year: 2010
  ident: ref77
  contributor:
    fullname: Tortora
– start-page: 223
  year: 1979
  ident: ref22
  article-title: Structure activity correlations of recent herbicides in photosynthetic reactions
  contributor:
    fullname: Trebst
– ident: ref71
  doi: 10.1016/j.ijfoodmicro.2015.02.009
– volume: 50
  start-page: 440
  year: 1995
  ident: ref87
  article-title: Antifungal and antialgal activity of piperidinopropyl esters of alkoxy substituted phenylcarbamic acids
  publication-title: Pharmazie
  contributor:
    fullname: Kralova
– ident: ref15
  doi: 10.1080/14786419.2017.1317776
– ident: ref54
  doi: 10.1128/AEM.00875-09
– ident: ref64
  doi: 10.1016/j.ejmech.2010.01.024
– year: 2012
  ident: ref91
– volume: 1208
  start-page: 361
  year: 2015
  ident: ref11
  article-title: Aryl-acetic and cinnamic acids as lipoxygenase inhibitors with antioxidant, anti-inflammatory, and anticancer activity
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-1441-8_26
  contributor:
    fullname: Hadjipavlou-Litina
– ident: ref45
  doi: 10.1016/j.ijfoodmicro.2006.04.046
– ident: ref8
  doi: 10.3390/molecules191219292
– ident: ref35
  doi: 10.1517/17460441.2016.1110142
– ident: ref43
  doi: 10.1021/jf980154m
– ident: ref62
  doi: 10.3390/molecules21081068
– ident: ref12
  doi: 10.2174/1871520615666150130111120
– year: 2017
  ident: ref18
– year: 2007
  ident: ref41
  contributor:
    fullname: Schwalbe
– ident: ref21
  doi: 10.1016/0005-2728(77)90157-8
– ident: ref79
  doi: 10.3390/ijms17081219
– volume: 3
  start-page: 403
  year: 2011
  ident: ref5
  article-title: Cinnamic acid derivatives: A new chapter of various pharmacological activities
  publication-title: J. Chem. Pharm. Res.
  contributor:
    fullname: Sharma
– ident: ref67
  doi: 10.1016/j.ejps.2011.04.012
– ident: ref50
  doi: 10.1021/la303286v
– ident: ref28
  doi: 10.2174/1573406410666140815125004
– ident: ref40
  doi: 10.1016/j.bmcl.2018.05.011
– ident: ref3
  doi: 10.1080/14756360902779326
– volume: 5
  start-page: 1064
  year: 2011
  ident: ref73
  article-title: Bipolaris sorokiniana’(Sacc.) Shoem.: The most destructive wheat fungal pathogen in the warmer areas
  publication-title: Aust. J. Crop Sci.
  contributor:
    fullname: Krishnendu
– ident: ref27
  doi: 10.1016/j.bmc.2013.08.030
– volume: 60
  start-page: 35
  year: 2011
  ident: ref55
  article-title: Antibiofilm activity of selected plant essential oils and their major components
  publication-title: Pol. J. Microbiol.
  doi: 10.33073/pjm-2011-005
  contributor:
    fullname: Budzynska
– ident: ref38
  doi: 10.1016/j.ejps.2015.06.009
– volume: 52
  start-page: 251
  year: 2008
  ident: ref88
  article-title: Isolation and characterization of EBR specific induced chitinases from tobacco (Nicotiana tabacum)
  publication-title: Acta Biol. Szeged.
  contributor:
    fullname: Szabo
– ident: ref39
  doi: 10.1111/1462-2920.12213
– ident: ref46
  doi: 10.3109/1040841X.2013.763219
SSID ssj0023259
Score 2.4037404
Snippet A series of sixteen ring-substituted -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was...
: A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was...
A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was...
A series of sixteen ring-substituted N -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2318
SubjectTerms Ampicillin
Antibiotics
Antifungal activity
antistaphylococcal activity
antitubercular activity
Benomyl
Biocompatibility
biofilm
Biofilms
Chloroplasts
cinnamamides
Ciprofloxacin
Cytotoxicity
Drug resistance
Electron transport
Fungicides
Isoniazid
Metabolism
Methicillin
Minimum inhibitory concentration
MTT assay
PET inhibition
Photosynthesis
Spinach
Staphylococcus aureus
structure–activity relationship
time-kill assay
toxicity
Tuberculosis
Vancomycin
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS-RAEC5UELyIb-OLCOsxmEl3-nH0iSDMRRe8hX5iFqdnMc7C_Hurk8wwIwtevKY70KmvK6mPVH8fwC9JlZOlJlnpNcuo1phShSoygxuA0dxwKeNB4YcnPnwRt3dRJmdu9RV7wjp54C5wl4VznBqqXZSeckpqj5Qgt5qJknnJbPv2zdmMTPVUi2BV37W5EyT1l_WfUTNozb2jucfCB6jV6f9fcfm1R3Lho3O_BZt9tZhedavchhUXdmC984-c7sLj0zRgAdfUTaqCTaOX_Mf7ZJSOfdrNiQikV6Z1iEBKHAeG43_uLR1m6n36ZuoQ1EiNauuaPfh9f_d885D17giZoVx8ZGZAPdJXZj3TghpFZa65IoUxXgrqjDSeCRMpHrJQ6kiprZY51k9Gasp9QfZhLYyDO4SUF0pYopX0ZUEx44VjclBwb3OqJGGDBC5mIav-diIYFZKHGNpqMbQJXMd4zudE6er2AgJa9YBW3wGawMkMjarPp6ZCiEU88C5lAufzYcyE-HtDBTee4BysHhlDAkgTOOjAm6-EROk9kuPdfAnWpaUuj4T6tVXbjhJrtCyPfuLZjmEDCy7RNhDyE1jDPeFOYbWxk7N2_34C7nv2kg
  priority: 102
  providerName: Directory of Open Access Journals
Title Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
URI https://www.ncbi.nlm.nih.gov/pubmed/30087309
https://www.proquest.com/docview/2108828699
https://search.proquest.com/docview/2085668714
https://pubmed.ncbi.nlm.nih.gov/PMC6121455
https://doaj.org/article/2ee74c4be6454ea9bf1400db6856f96d
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7cguCLeDe2LhH0Md0kM5nLY60tleIiVMG3MFeNbCZl0xX23_fMJFl2xSdfMxMYzoX5vuSc7yD0XhBpRaVwVjlFM6IUpFQpy0xDAFCSayZEaBS-umHLH_zTRZDJqaZemFi0r1Vz6lftqW9-xdrK21Yvpjqxxdcv50H1ilTVYoZmgA0nij6yLAyAfqhwx8DnF83vti_iXO8izObDQYMNh_LDvWsoqvX_C2L-XSm5d_VcPkGPR8yYng1ne4oeWP8MPRymSG6fo-ubrQcY1zd9Kr1Jw0T5u_WmTTuXDnuCH9IzHedEADEOC8vuj12ly0yutyvdeC9b2TbG9i_Q98uLb-dX2TgjIdOE8btMF8QBiaXGUcWJlkTkiklcau0EJ1YL7SjXgegBFyUWV8ookQOK0kIR5kr8Eh35ztvXKGWl5AYrKVxVEsh7bqkoSuZMTqTAtEjQh8lk9e0ghVEDhQhWrvetnKCPwZ67PUHAOj7o1j_r0Y11aS0jmigbFMWsFMoB08uNoryiTlCToJPJG_WYVX0N9JSHtnchEvRutwz5EH5ySG-7DewBDEkp0ECSoFeD83YnmZyfIHbg1oOjHq5ACEbN7THk3vz3m8foEWAtHmsH2Qk6gkCwb9GsN5s5IPnP1_P4NWAeY_keFAj4Xg
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RIgQX3o9AgSDBMd0kdvw4ltJqUdsVUovELbIdG4I23mrTRdp_zziP1S7i1GvGkSx_M_F8ysw3AB8lVVYWmiSF0yyhWmNI5SpPDDoAo6nhUoZG4ekln_0QX06CTE4x9sJ0RftG14d-3hz6-ldXW3ndmMlYJzb5dnEcVK9oUUz24C7Ga5qOJH3gWQRT-r7GnSCjn9S_mzbrJntnYTofCSpsJBQgbl1EnV7__5LMf2slty6f00e33PZjeDhkm_FRb34Cd6x_Cvf6-ZPrZ3B2ufaYALZ1GytfxWEW_c1y1cQLF_drAoLxkekmTCClDobZ4o-dx7NELddzU3uvGtXUlW2fw_fTk6vjaTJMV0gM5eImMRl1SH9Z5ZgW1CgqU80VyY1xUlBrpHFMmEARkcVSSwpdaZli_mWkptzl5AXs-4W3ryDmuRIV0Uq6Iqf4xRCWySznrkqpkoRlEXwaj7q87kU0SiQfAZ1yG50IPgccNmuC9HX3YLH8WQ4nWebWcmqotkGLzCqpHXLEtNJMFMxJVkVwMKJYDvHYlkhsRWiYlzKCDxszRlL4PaK8XaxwDWafjCGBpBG87EHf7GR0mgj4jjvsbHXXgl7QqXUPqL--9Zvv4f706uK8PP86O3sDDzBjE10FIj-AfXQK-xb22mr1rouBv3NqC_8
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoEagX3tBAgSDBMc3Djh_H0nZVVFhVKkjcIj9L0MZZbbpI--8ZJ9nVLuIE13gijTwz8fcp428Qei-ItKJUOCmdoglRCkqqkEWiIQEoyTQTIlwUvrhm0-_87DzI5GxGffVN-1rVx37WHPv6R99bOW90uu4TS6--nAbVK1KW6dy4dA_dhZrNijVRH7kWBlg_9LljYPVp_bPp8n66dx4m9OGgxIZDE-LWYdRr9v8NaP7ZL7l1AE0e_ofrj9CDEXXGJ4PJY3TH-ifo3jCHcvUUXV6vPADBru5i6U0cZtLfLpZN3Lp4sAmRjE90P2kCqHVYmLa_7CyeJnKxmunae9nIpja2e4a-Tc6_nl4k45SFRBPGbxOdEwc0mBpHFSdaEpEpJnGhtROcWC20o1wHqghsllhcKqNEBjhMC0WYK_BztO9bbw9RzArJDVZSuLIg8OXgloq8YM5kRApM8wh9WG93NR_ENCogISFC1XaEIvQxxGJjEySw-wft4qYad7MqrGVEE2WDJpmVQjngiplRlJfUCWoidLSOZDXWZVcBweXh4rwQEXq3WYaKCr9JpLftEmwAhVIKRJJE6MUQ-I0n68SJENtJiR1Xd1cgE3rV7jHyL__5zbfo_tXZpPr8aXr5Ch0AcON9IyI7QvuQE_Y12uvM8k1fBr8B4VoOfw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+Spectrum+of+Biological+Activities+of+Novel+N-arylcinnamamides&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Pospisilova%2C+Sarka&rft.au=Kos%2C+Jiri&rft.au=Michnova%2C+Hana&rft.au=Kapustikova%2C+Iva&rft.date=2018-08-07&rft.pub=MDPI+AG&rft.issn=1661-6596&rft.eissn=1422-0067&rft.volume=19&rft.issue=8&rft.spage=2318&rft_id=info:doi/10.3390%2Fijms19082318&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon